Société de Chimie Thérapeutique – Evotec-SCT Prize
Expire le 20 mars 2026
The successful candidate will be selected based on outstanding innovation and applied state-of-the-art molecular design skills that have contributed to a demonstrated advance to drug discovery capabilities. In particular, the assessment panel are keen to recognize “drug hunters” who have demonstrated excellence in drug design resulting in highly informative novel molecules that significantly impact a drug discovery project. Submissions preferably should be the subject of a published (or accepted) scientific article, covers a “break-through” discovery or innovative technology/method, and may include the application of machine learning and artificial intelligence (AI).